CZ261390A3 - Deoxyspergualintrihydrochlorid v krystalické formě beta a způsob jeho výroby - Google Patents
Deoxyspergualintrihydrochlorid v krystalické formě beta a způsob jeho výroby Download PDFInfo
- Publication number
- CZ261390A3 CZ261390A3 CS902613A CS261390A CZ261390A3 CZ 261390 A3 CZ261390 A3 CZ 261390A3 CS 902613 A CS902613 A CS 902613A CS 261390 A CS261390 A CS 261390A CZ 261390 A3 CZ261390 A3 CZ 261390A3
- Authority
- CZ
- Czechia
- Prior art keywords
- crystals
- deoxyspergualine
- hydrochloride
- trihydrochloride
- crystalline
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title description 16
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000013078 crystal Substances 0.000 claims description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000002441 X-ray diffraction Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 abstract description 10
- 239000006188 syrup Substances 0.000 abstract description 8
- 235000020357 syrup Nutrition 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000007900 aqueous suspension Substances 0.000 abstract description 4
- 230000000259 anti-tumor effect Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- AXSPHUWXYSZPBG-OKUPDQQSSA-N n-[(1s)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide;trihydrochloride Chemical compound Cl.Cl.Cl.NCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCN=C(N)N AXSPHUWXYSZPBG-OKUPDQQSSA-N 0.000 abstract 2
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 description 12
- 230000008025 crystallization Effects 0.000 description 12
- AXSPHUWXYSZPBG-UHFFFAOYSA-N Gusperimus hydrochloride Chemical compound Cl.Cl.Cl.NCCCNCCCCNC(=O)C(O)NC(=O)CCCCCCN=C(N)N AXSPHUWXYSZPBG-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 239000010439 graphite Substances 0.000 description 4
- 229910002804 graphite Inorganic materials 0.000 description 4
- 238000002411 thermogravimetry Methods 0.000 description 4
- 238000004455 differential thermal analysis Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000002076 thermal analysis method Methods 0.000 description 2
- MNKRWWHDVSPGIV-UHFFFAOYSA-N 7-(diaminomethylideneamino)heptanamide Chemical compound NC(=O)CCCCCCNC(N)=N MNKRWWHDVSPGIV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ATHGHQPFGPMSJY-UHFFFAOYSA-N Spermidine Natural products NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- -1 glyoxylyl spermidine Chemical compound 0.000 description 1
- 229960002706 gusperimus Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- IDINUJSAMVOPCM-INIZCTEOSA-N n-[(1s)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide Chemical compound NCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCN=C(N)N IDINUJSAMVOPCM-INIZCTEOSA-N 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13287889 | 1989-05-29 | ||
| JP13287989 | 1989-05-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ283320B6 CZ283320B6 (cs) | 1998-02-18 |
| CZ261390A3 true CZ261390A3 (cs) | 1998-02-18 |
Family
ID=26467336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS902613A CZ261390A3 (cs) | 1989-05-29 | 1990-05-28 | Deoxyspergualintrihydrochlorid v krystalické formě beta a způsob jeho výroby |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0400889B1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR940005918B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1017621B (cg-RX-API-DMAC7.html) |
| AR (1) | AR247877A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU626676B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2017361C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ261390A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69006105T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2062363T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HU207844B (cg-RX-API-DMAC7.html) |
| PL (1) | PL163358B1 (cg-RX-API-DMAC7.html) |
| TW (2) | TW275620B (cg-RX-API-DMAC7.html) |
| YU (1) | YU48230B (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5862152A (ja) * | 1981-10-08 | 1983-04-13 | Microbial Chem Res Found | Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法 |
| JPS58198455A (ja) * | 1982-05-17 | 1983-11-18 | Microbial Chem Res Found | （−）−１５−デオキシスパガリンおよびその製造法並びにその中間体 |
| ES2039213T3 (es) * | 1986-04-04 | 1993-09-16 | Microbial Chemistry Research Foundation | Procedimiento para producir nuevos compuestos relacionados con espergualina. |
| EP0467280B1 (en) * | 1990-07-20 | 1994-09-28 | Nippon Kayaku Kabushiki Kaisha | Novel spergualin-related compound and use thereof |
-
1990
- 1990-05-14 YU YU93690A patent/YU48230B/sh unknown
- 1990-05-21 TW TW083110203A patent/TW275620B/zh active
- 1990-05-21 TW TW079104099A patent/TW275619B/zh active
- 1990-05-22 AU AU55800/90A patent/AU626676B2/en not_active Ceased
- 1990-05-23 EP EP90305617A patent/EP0400889B1/en not_active Expired - Lifetime
- 1990-05-23 CA CA002017361A patent/CA2017361C/en not_active Expired - Lifetime
- 1990-05-23 ES ES90305617T patent/ES2062363T3/es not_active Expired - Lifetime
- 1990-05-23 DE DE69006105T patent/DE69006105T2/de not_active Expired - Fee Related
- 1990-05-28 CZ CS902613A patent/CZ261390A3/cs not_active IP Right Cessation
- 1990-05-28 HU HU903227A patent/HU207844B/hu not_active IP Right Cessation
- 1990-05-28 CN CN90103806A patent/CN1017621B/zh not_active Expired
- 1990-05-28 PL PL90285375A patent/PL163358B1/pl not_active IP Right Cessation
- 1990-05-28 AR AR90316949A patent/AR247877A1/es active
- 1990-05-28 KR KR1019900007699A patent/KR940005918B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR900018015A (ko) | 1990-12-20 |
| AU5580090A (en) | 1990-11-29 |
| EP0400889A1 (en) | 1990-12-05 |
| CN1017621B (zh) | 1992-07-29 |
| AR247877A1 (es) | 1995-04-28 |
| CZ283320B6 (cs) | 1998-02-18 |
| EP0400889B1 (en) | 1994-01-19 |
| TW275619B (cg-RX-API-DMAC7.html) | 1996-05-11 |
| HU207844B (en) | 1993-06-28 |
| AU626676B2 (en) | 1992-08-06 |
| DE69006105T2 (de) | 1994-07-07 |
| CA2017361A1 (en) | 1990-11-29 |
| TW275620B (cg-RX-API-DMAC7.html) | 1996-05-11 |
| YU48230B (sh) | 1997-08-22 |
| DE69006105D1 (de) | 1994-03-03 |
| CN1047670A (zh) | 1990-12-12 |
| KR940005918B1 (ko) | 1994-06-24 |
| CA2017361C (en) | 1996-09-03 |
| ES2062363T3 (es) | 1994-12-16 |
| HU903227D0 (en) | 1990-10-28 |
| HUT54633A (en) | 1991-03-28 |
| PL163358B1 (pl) | 1994-03-31 |
| PL285375A1 (en) | 1991-08-12 |
| YU93690A (sh) | 1992-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5488150A (en) | Crystals of N-(trans-4-isopropylcyclohexycarbonyl)-D-phenylalanine and methods for preparing them | |
| HU226861B1 (en) | Magnesium salt of omeprazole | |
| JPH0144176B2 (cg-RX-API-DMAC7.html) | ||
| JPH0415205B2 (cg-RX-API-DMAC7.html) | ||
| EP0422497B1 (en) | Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them | |
| CA1212381A (en) | Crystal modifications of ( )-catechin and processes for their production | |
| JPS5835967B2 (ja) | 微細結晶ワルフアリンの製造方法 | |
| EP3390358B1 (en) | Crystalline eravacycline bis-hydrochloride | |
| CZ20031397A3 (cs) | Nové krystalické a solvatované formy ondansetron hydrochloridu a způsoby jejich přípravy | |
| CZ261390A3 (cs) | Deoxyspergualintrihydrochlorid v krystalické formě beta a způsob jeho výroby | |
| RU2586117C2 (ru) | Кристаллизация гидрохлорида эпирубицина | |
| CN121152781A (zh) | 合成方法 | |
| EP1463712A1 (en) | New anhydrous crystalline forms of gabapentin | |
| EP0239015B1 (en) | Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter | |
| KR100540021B1 (ko) | 신규한 결정 구조를 갖는 에리트로마이신 유도체 및 그의제조 방법 | |
| JPH06192228A (ja) | 結晶性（ｒ）−（−）−２−シクロヘプチル−ｎ−メチルスルフオニル−［４−（２−キノリニルメトキシ）−フエニル］−アセトアミド | |
| US6747012B1 (en) | Crystalline anthracycline antibiotic and process for producing the same | |
| CN111566112B (zh) | 埃格列净的晶型及其制备方法 | |
| JP2677906B2 (ja) | パラ−アミノベンゼンスルファニルアミドの物理的に安定した結晶性α−変態の調製方法 | |
| EP1264821A1 (en) | Novel crystal of stilbene derivative and process for producing the same | |
| US4786754A (en) | Crystalline upsilon-form bestatin and processes for its preparation | |
| JP2775047B2 (ja) | 塩酸デオキシスパガリンのα型結晶及びその製造方法 | |
| KR940008595B1 (ko) | I-β-D-아라비노푸라노실시토신-5'-스테아릴포스페이트 모노나트륨염 모노하이드레이트 및 이 모노하이드레이트를 함유하는 약제 조성물 | |
| CN116178274A (zh) | 氯比普兰硫酸盐晶型及其制备方法 | |
| US6313350B1 (en) | Form a of fluoxetine hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MK4A | Patent expired |
Effective date: 20100528 |